A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)
Clinical trial NCT01657370 · COMPLETED
Trial details
- NCT number
- NCT01657370
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.